On Monday, SandboxAQ, an American enterprise specializing in artificial intelligence (AI) and quantum technology, entered into a strategic partnership with Bahrain's sovereign wealth fund, Mumtalakat. The collaboration is geared towards expediting drug discovery processes and establishing a biotechnology asset portfolio valued at $1 billion. Under the terms of the agreement, Mumtalakat will secure a license to leverage SandboxAQ's sophisticated, large-scale quantitative models. These models, which have been extensively trained in the realms of physics, chemistry, and biology, are poised to significantly accelerate drug development initiatives and scientific research endeavors.
